Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 4/20 | 0.36 |
| ▸ | CA12 | O43570 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | MMP2 | P08253 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12981430 | 1.00 | SHBG (0.39) | SHBGNPSR1EPHX1CA12CA1 | |
| SCHEMBL2685932 | 0.98 | SHBG (0.35) | SHBGNPSR1EPHX1CA12CA1 | |
| SCHEMBL2465450 | 0.85 | NAAA (0.37) | SHBGNPSR1EPHX1CA12CA1 | |
| SCHEMBL2687861 | 0.83 | NAAA (0.35) | SHBGNPSR1EPHX1CA12CA1 | |
| SCHEMBL15549705 | 0.83 | NPSR1 (0.37) | SHBGNPSR1EPHX1CA12CA1 | |
| SCHEMBL2686498 | 0.81 | MMP2 (0.38) | SHBGNPSR1EPHX1CA12CA1 | |
| SCHEMBL2468404 | 0.81 | NAAA (0.47) | EPHX1EPHX2TSHR | |
| SCHEMBL2687252 | 0.80 | NAAA (0.40) | EPHX1TSHR | |
| SCHEMBL2687691 | 0.80 | NPSR1 (0.39) | SHBGNPSR1EPHX1CA12CA1 | |
| SCHEMBL2688642 | 0.80 | NAAA (0.50) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3118226-A1 | HIGH ACTIVITY CATALYST FOR OLEFIN POLYMERIZATION | BASF Corporation (US) | 2017-01-18 | — | — | EP | claimed |
| EP-2782938-B1 | HIGH ACTIVITY CATALYST FOR OLEFIN POLYMERIZATION | BASF CORP (US) | 2016-08-31 | — | — | EP | claimed |
| EP-2782938-A1 | HIGH ACTIVITY CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND METHOD OF USING THE SAME | BASF Corporation (US) | 2014-10-01 | — | — | EP | claimed |
| CN-104053682-A | High activity catalyst component for olefin polymerization and method of using the same | BASF SE | 2014-09-17 | — | — | CN | claimed |
| WO-2013077837-A1 | HIGH ACTIVITY CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND METHOD OF USING THE SAME | BASF CORPORATION (US) | 2013-05-30 | — | — | WO | claimed |
| US-8227370-B2 | High activity catalyst component for olefin polymerization and method of using the same | BASF CORPORATION (US) | 2012-07-24 | — | — | US | claimed |
| US-20120116031-A1 | High Activity Catalyst Component for Olefin Polymerization and Method of Using the Same | BASF CORPORATION (US) | 2012-05-10 | — | — | US | claimed |
| EP-3118226-A1 | HIGH ACTIVITY CATALYST FOR OLEFIN POLYMERIZATION | BASF Corporation (US) | 2017-01-18 | — | — | EP | disclosed |
| EP-2782938-B1 | HIGH ACTIVITY CATALYST FOR OLEFIN POLYMERIZATION | BASF CORP (US) | 2016-08-31 | — | — | EP | disclosed |
| US-8227370-B2 | High activity catalyst component for olefin polymerization and method of using the same | BASF CORPORATION (US) | 2012-07-24 | — | — | US | disclosed |
| US-20120116031-A1 | High Activity Catalyst Component for Olefin Polymerization and Method of Using the Same | BASF CORPORATION (US) | 2012-05-10 | — | — | US | disclosed |
| WO-2010148006-A1 | HEPATITIS C VIRUS INHIBITORS | ENANTA PHARMACEUTICALS, INC. (US) | 2010-12-23 | — | — | WO | disclosed |